Friday 10 October 2014

US approves pricey new pill against hepatitis C

Protesters lay on the floor in front of a Gilead Sciences stand to denounce the high price of Sofosbuvir, a drug that treats Hepatitis C, on April 29, 2014 in southern France Washington (AFP) - US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment